Kendra Wong
Comptroller/Controller/Auditor presso LENSAR, INC.
Patrimonio netto: 123 892 $ in data 30/04/2024
Profilo
Kendra W.
Wong is currently working as the Principal Accounting Officer at LENSAR, Inc. She previously worked as the Assistant Controller-Subsidiary Operations at PDL BioPharma, Inc. from 2018 to 2021.
Ms. Wong holds an MBA from Arizona State University and an undergraduate degree from the University of California, Davis.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LENSAR INC
0.32% | 06/05/2024 | 36 120 ( 0.32% ) | 123 892 $ | 30/04/2024 |
Posizioni attive di Kendra Wong
| Società | Posizione | Inizio |
|---|---|---|
| LENSAR, INC. | Comptroller/Controller/Auditor | 11/01/2022 |
Precedenti posizioni note di Kendra Wong
| Società | Posizione | Fine |
|---|---|---|
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01/03/2021 |
Formazione di Kendra Wong
| University of California, Davis | Undergraduate Degree |
| Arizona State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LENSAR, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Borsa valori
- Insiders
- Kendra Wong
